Results: PBMCs immunophenotyping revealed the presence of a significantly higher percentage of CD8+ T cells co-expressing the CD4 marker (CD4dimCD8+ T cells) in patients with MAS or with other forms of sHLH, compared to patients with inactive or active sJIA. This evidence concerns the gene CD8A and macrophage activation syndrome.